Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients
Enrolling by invitationOBSERVATIONAL
Enrollment
45
Participants
Timeline
Start Date
January 21, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
Conditions
Acute Myeloid Leukemia
Trial Locations (1)
100730
Peking Union Medical College Hospital, Beijing
All Listed Sponsors
lead
Peking Union Medical College Hospital
OTHER
NCT06162325 - Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients | Biotech Hunter | Biotech Hunter